Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News

8/26/2021 Ranking of Russian Pharmaceutical Distributors (Q1–Q2 2021)

Serious changes had begun on the market even before Katren completed its purchase of a controlling stake in the Erkapharm group. First, the structure of Erkapharm’s suppliers began to change—obviously, in favor of the new owner. But most importantly, the company seems to be preparing for a long overdue global reform of its retail. A number of Erkafarm pharmacies have been rebranded into Apteka.ru, and the process can continue if proven effective.

8/6/2021 Survey by RNC Pharma and Medvestnik: Only 1% of Russian Doctors Are Okay with the Current Pay System

68% of Russian doctors are pessimistic about the possibility of reforming the pay system in the healthcare industry, according to a survey conducted by the RNC Pharma analyst company and the platform for doctors Medvestnik. 59% of them “do not believe the situation can change at all” and another 9% think that “those who wanted a decent salary left the state healthcare a long time ago.”

8/3/2021 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 1.3% of Russian Doctors Have a Fake Vaccine Certificate

Most Russian doctors prefer to actually get vaccinated against COVID-19 and not buy a fake certificate, according to a survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Around 69% of the study participants were already vaccinated at the time of the survey, and another 15% were ready to get the vaccine at the earliest opportunity. About 10% had medical reasons preventing them from getting vaccinated and did not need a fake card.

8/2/2021 Survey by RNC Pharma and Medvestnik: 50% of Russian Health Workers Do not Want to Get Vaccinated due to Lack of Research

Out of 1,119 health workers (doctors, nurses, laboratory assistants, etc.) who took part in the survey conducted by the RNC Pharma analyst company and the platform for doctors Medvestnik, only 11%, or 129 people, refuse to get vaccinated. Only 7% of those has objective reasons, i.e. medical contraindications, another 20% had a high antibody titer after a previous infection, which might allow them to postpone vaccination, but not to avoid it forever.

7/26/2021 Survey by RNC Pharma and Medvestnik: 66% of Russian Health Workers Already Vaccinated against COVID-19

Out of 1,119 health workers (doctors, nurses, laboratory assistants, etc.) who took part in the survey conducted by the RNC Pharma analyst company and the platform for doctors Medvestnik, 66% have already been vaccinated from COVID-19 (Fig. 1). Another 12% have not yet had time to get vaccinated, but are willing to do it in the near future.

7/23/2021 Database Update: Audit of Veterinary Drug Retail Sales in Russia (June and Q1–Q2 2021)

Between Q1 and Q2 2021, the sales of veterinary drugs in the Russian retail market amounted to 11 billion rubles (retail prices, VAT included), up only 3.8% in monetary terms (rubles) from 2020, which is much lower than the inflation rate of 8.3%. In physical terms, the market volume amounted to 93 million minimum dosage units (MDU), with the growth rates of +3.1%.

7/7/2021 Pharmaceutical Drug Production in Russia (May 2021)

Between January and May 2021, Russian manufacturers produced 239.1 billion rubles worth of pharmaceutical drugs (manufacturer’s prices, VAT included), up 26% from the same period last year in monetary terms (rubles). The growth rate in physical terms (packages), however, is still negative, -9.2%, with the production volume of 1.7 billion packages. Despite the serious drop in packages, the growth rate in MDUs (minimum dosage units) is much better: -1.7%, 32.6 billion MDUs produced. Apart from the falling demand, the standard package has changed.

6/25/2021 Survey by RNC Pharma and Medvestnik: Only 3% of Russian Doctors Have not Dealt with Patients Trying to Extort Money from Clinics

At least 70% of doctors often have to deal with aggressive patients pressuring them in order to obtain money from the healthcare facility, according to a survey conducted by the RNC Pharma analyst company and the platform for doctors Medvestnik. 46% of them encounter such patients from time to time, while 24% say that it occurs “regularly.”

6/22/2021 Database Update: Audit of Veterinary Drug Retail Sales in Russia (May 2021)

Between January and May 2021, the sales of veterinary drugs in the Russian retail market amounted to 9.3 billion rubles (retail prices, VAT included), down 6.1% from January–May 2020. Despite the high inflation rates and the prices up 11.7%, the growth rate of the sales volume in physical terms (minimum dosage units, MDU) was +7.4%. The sales volume of veterinary drugs amounted to 80.3 million MDUs.

6/17/2021 Inflation Rates for APIs Imported to Russia in 2011–2020

The Laspeyres price index for the import of APIs to Russia in 2020 reached an all-time high of 23.9%. Over the past 10 years, a more or less comparable index was witnessed back in 2015 (19.9%), when the increase in prices was caused by the devaluation of the Russian ruble, with the US dollar increasing by almost 60% and the euro by about 33% against the ruble.